About this course

Stroke prevention is one of the cornerstones in the management of patients with atrial fibrillation (AF). AF increases stroke risk and is prevented using vitamin K antagonists or non-vitamin K antagonist oral anticoagulants (NOACs). The use of NOACs has led to improved clinical outcomes in AF patients in terms of stroke prevention. This e-learning module summarizes the data on the efficacy and safety of NOACs, their guidelines-based indications, and the reversal agents for NOAC-induced bleeding.

Learning outcomes

• Identify potential NOACs for specific patients
• Identify reversal agents for NOAC-induced bleeding

Topics covered

• Stroke risk stratification
• Vitamin K antagonists versus NOACs
• The four approved NOACs
• NOACs in the guidelines
• Specific, non-specific, and emerging reversal agents
• Patient specific indications for using each NOAC
• Acceptability, accessibility, and affordability of NOACs